The Helmholtz Institute for RNA-based Infection Research (HIRI) at Julius-Maximilians-Universität Würzburg is offering a postdoctoral position focused on the development and application of programmable RNA antibiotics using antisense oligonucleotide (ASO) technology. The successful candidate will join a multidisciplinary team to advance research in molecular biology, biotechnology, genomics, chemistry, and pharmaceutical sciences. Key responsibilities include designing and applying programmable RNA antibiotics to target various microbes and phages, modulating bacterial gene expression via ASOs, and exploring innovative therapeutic applications such as phage therapy and antimicrobial resistance. The position offers a salary according to the German public grid (TV-L) and is initially funded for two years, with the possibility of extension. Applicants should have a PhD in a relevant field and strong experimental and analytical skills. The laboratory is located in Würzburg, Germany, and provides a collaborative environment for cutting-edge research in RNA-based infection control. Interested candidates should contact Joerg Vogel by email and cc Monika Schraut for application details. This opportunity is ideal for researchers interested in molecular therapeutics, antimicrobial resistance, and RNA technology.